Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Longitudinal Observational Study of Patients Undergoing Therapy for Immune-Mediated Inflammatory Skin Conditions

NCT03661866 is registered in ClinicalTrials.gov with Target PharmaSolutions, Inc. as lead sponsor.

NCT NCT03661866
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03661866 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Longitudinal Observational Study of Patients Undergoing Therapy for Immune-Mediated Inflammatory Skin Conditions
Lead sponsor
Target PharmaSolutions, Inc.
Phase
Observational
Overall status
Active, not recruiting
Start date
December 21, 2018
Completion date
December 31, 2050
Enrollment
15,000 (estimated)
Sites
62

Conditions

As the registry lists them; a condition with its own page is linked.

alopecia areata, atopic dermatitis, chronic spontaneous urticaria, hidradenitis suppurativa, psoriasis, vitiligo